The in vitro fertilization market is on a strong upward trajectory, with projections indicating a significant increase in valuation from USD 819.8 million in 2024 to USD 1,940.8 million by 2034. This growth is driven by a compound annual growth rate (CAGR) of 9% over the next decade, reflecting the rising incidence of infertility and advancing reproductive technologies.
The anticipated expansion of the IVF market highlights the increasing demand for assisted reproductive technologies as more individuals and couples seek effective solutions to overcome infertility challenges. The 9% CAGR is indicative of a dynamic and rapidly evolving sector, supported by continuous innovations and improvements in IVF techniques.
The growing prevalence of infertility issues globally, combined with heightened awareness and acceptance of assisted reproductive methods, is propelling the market’s growth. This trend is expected to drive substantial investment in research and development, leading to enhanced treatment options and improved success rates for IVF procedures.
Get your PDF – Sample Report
IVF Market Dominates Infertility Treatment Landscape
Presently, the worldwide infertility treatment market is dominated by the in vitro fertilization sector. As more people and couples looking for reproductive solutions become aware of the advantages of IVF, this dominance is expected to grow.
This growth is primarily driven by two key factors:
- Rising Demand for IVF Procedures: A declining global fertility rate coupled with growing awareness about the improved success rates of IVF is leading to a surge in demand for these procedures.
- Increased Accessibility to Fertility Treatments: The rapid rise in the number of IVF clinics and hospitals worldwide is making fertility treatments more readily available, creating substantial growth opportunities within the market.
Some of the key takeaways from the report are highlighted below
- The demand for egg banking services is expected to surge considerably in the coming years
- Europe will lead in the in vitro fertilization banking services market throughout the forecast period
- Latin America will emerge lucrative in the in vitro fertilization banking services market in the coming years
- The rising demand for andrology services will augment growth prospects
- Fresh donor egg cycle services will remain highly sought-after among various egg banking services available
“The launch of advanced IVF techniques such as genetic diagnosis, three parent IVF, percutaneous epidydimal sperm aspiration, three-parent, and others are considered revolutionary findings in the field of medicine. Besides the rising prevalence of fertility concerns, increasing awareness among patients and their willingness to spend on advanced treatment procedures will create lucrative growth opportunities for the market.”
Competitive Landscape:
The worldwide in vitro fertilization industry is extremely competitive due to the existence of numerous regional and local firms. Leading in vitro fertilization (IVF) companies are constantly concentrating on growing their service and product offerings in order to profit. In addition, in order to obtain a competitive edge in the international IVF market, they have implemented a number of initiatives, including partnerships, mergers, acquisitions, collaborations, and the introduction of awareness campaigns. For example,
- In September 2029, Hamilton Thorne Ltd., a leading worldwide provider of precision instruments, consumables, software, and services to Assisted Reproductive Technologies (ART) and developmental biology research markets, received clearance to market GM501 wash media, its first Gynemed branded media product, in the USA
- In May 2021, Ro, the healthcare technology company, announced the acquisition of Modern Fertility, a high-growth reproductive health company.
- In September 2019, Fujifilm Irvine Scientific, Inc., launched Vit Kit-NX, a new vitrification solution for IVF.
Customization Available – Here
Key Companies Covered:
Vitrolife, Thermo Fisher Scientific Inc, Cook Group, IVFtech ApS, Esco Micro, Genea Limited, Fujifilm Irvine Scientific, The Baker Company, and Kitazato Corporation.
Key Segments:
By Product:
- Equipment
- Reagents and Media
- Accessories
By Cycle:
- Fresh non-donor cycle
- Frozen non-donor IVF cycle
- Frozen donor IVF cycle
- Fresh donor IVF cycle
By End User:
- Fertility Clinics
- Hospitals & Surgical Centers
- Cryobank and Research Institutes
By Type:
- Conventional IVF
- IVF with ICSI
- IVF with Donor Eggs
- North America
- Latin America
- Middle East and Africa
- Asia Pacific
- Europe
Secure Your Market Analysis: Purchase Now to Access
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
